NICE backs new option for Crohn’s disease

28th April 2017 Uncategorised 0

The National Institute for Health and Care Excellence is backing the use of Janssen’s biologic Stelara to treat adult patients with moderately to severely active Crohn’s disease.

More: NICE backs new option for Crohn’s disease
Source: News